3-3845037-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_020873.7(LRRN1):c.396C>T(p.Thr132Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000957 in 1,613,926 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0053 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 4 hom. )
Consequence
LRRN1
NM_020873.7 synonymous
NM_020873.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.25
Genes affected
LRRN1 (HGNC:20980): (leucine rich repeat neuronal 1) Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be integral component of membrane. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
SUMF1 (HGNC:20376): (sulfatase modifying factor 1) This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-3845037-C-T is Benign according to our data. Variant chr3-3845037-C-T is described in ClinVar as [Benign]. Clinvar id is 716843.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.24 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00529 (805/152080) while in subpopulation AFR AF = 0.0188 (779/41450). AF 95% confidence interval is 0.0177. There are 9 homozygotes in GnomAd4. There are 366 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 805 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRN1 | NM_020873.7 | c.396C>T | p.Thr132Thr | synonymous_variant | Exon 2 of 2 | ENST00000319331.4 | NP_065924.3 | |
LRRN1 | NM_001324188.2 | c.396C>T | p.Thr132Thr | synonymous_variant | Exon 3 of 3 | NP_001311117.1 | ||
LRRN1 | NM_001324189.2 | c.396C>T | p.Thr132Thr | synonymous_variant | Exon 3 of 3 | NP_001311118.1 | ||
LRRN1 | XM_047448644.1 | c.396C>T | p.Thr132Thr | synonymous_variant | Exon 2 of 2 | XP_047304600.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00530 AC: 806AN: 151962Hom.: 9 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
806
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00148 AC: 372AN: 251112 AF XY: 0.00106 show subpopulations
GnomAD2 exomes
AF:
AC:
372
AN:
251112
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000506 AC: 740AN: 1461846Hom.: 4 Cov.: 75 AF XY: 0.000437 AC XY: 318AN XY: 727230 show subpopulations
GnomAD4 exome
AF:
AC:
740
AN:
1461846
Hom.:
Cov.:
75
AF XY:
AC XY:
318
AN XY:
727230
show subpopulations
African (AFR)
AF:
AC:
628
AN:
33480
American (AMR)
AF:
AC:
38
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39678
South Asian (SAS)
AF:
AC:
3
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
27
AN:
1111996
Other (OTH)
AF:
AC:
42
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
46
93
139
186
232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00529 AC: 805AN: 152080Hom.: 9 Cov.: 32 AF XY: 0.00492 AC XY: 366AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
805
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
366
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
779
AN:
41450
American (AMR)
AF:
AC:
13
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5164
South Asian (SAS)
AF:
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
5
AN:
67996
Other (OTH)
AF:
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
41
83
124
166
207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.